Expression of P-glycoprotein in lymphocytes from children with nephrotic syndrome, depending on their steroid response

Pediatric Nephrology

Volumn 21, Issue 9, 2006, Pages 1274-1280

  Wasilewska, Anna ^a   Zoch Zwierz, Walentyna ^a   Pietruczuk, Miroslawa ^a   Zalewski, Grzegorz ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Children; Glucocorticoids; Nephrotic syndrome; P glycoprotein

Indexed keywords

AZATHIOPRINE; CD3 ANTIGEN; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; PREDNISONE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DEPENDENCE; DRUG RESPONSE; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE RISK; STATISTICAL SIGNIFICANCE; STEROID THERAPY;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD3; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; HUMANS; LYMPHOCYTES; MALE; NEPHROTIC SYNDROME; P-GLYCOPROTEIN; TREATMENT OUTCOME;

EID: 33746963885     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0187-2     Document Type: Article

References (28)

1. Nasi M, Aedelmann CM, Berstein J, Barnett HL (1992) The nephrotic syndrome. In: Edelmann CM, Berstein J, Meadow SR, Spitzer A, Travis LB (eds) Pediatric kidney disease, vol 2. Little, Brown, Boston, pp 1247-1266
2. No authors listed (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 98:561-564
3. Ehrich JH, Brodehl J (1993) Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft fur Padiatrische Nephrologie. Eur J Pediatr 152:357-361
4. Leung DJ, Bloom JW (2003) Update on glucocorticoid action and resistance. J Allergy Clin Immunol 111:3-22
5. Hearing SD, Norman M, Probert CS, Haslam N, Dayan CM (1999) Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes. Gut 45:382-388
6. Lane SJ, Lee TH (1996) Corticosteroid resistance in other disease states and tissues. Am J Respir Crit Care Med 154:S62-S65
7. Ling V (1997) Multidrug resistance: Molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 40 [Suppl]:S3-S8
8. Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152-162
9. Klimecki WT, Futscher BW, Grogan TM, Dalton WS (1994) P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 83:2451-2458
10. Ford JM (1995) Modulators of multidrug resistance. Preclinical studies. Hematol Oncol Clin North Am 9:337-361
11. No authors listed (1982) Early identification of frequent relapsers among children with minimal change nephrotic syndrome. A report of the international study of kidney disease in children. J Pediatr 101:514-518
12. No authors listed (1987) Cyclophosphamide treatment of steroid dependent nephrotic syndrome: Comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pádiatrische Nephrologie. Arch Dis Child 62:1102-1106
13. List AF, Kopecky KJ, Willman CL, Head DR, Slovak ML, Douer D, Dakhil SR, Appelbaum FR (2002) Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase. Blood 100:1910-1912
14. Siiteri PK, Murai JT, Hammond GL, Nisker JA, Raymoure WJ, Kuhn RW (1982) The serum transport of steroid hormones. Recent Prog Horm Res 38:457-510
15. Beck WT, Grogan TM (1997) Methods to detect P-glycoprotein and implications for other drug resistance-associated proteins. Leukemia 11:1107-1109
16. Tsujimura S, Saito K, Nakayamada S, Nakano K, Tsukada J, Kohno K, Tanaka Y (2004) Transcriptional regulation of multidrug resistance-1 gene by interleukin-2 in lymphocytes. Genes Cells 9:1265-1273
17. Tsuruo T (1983) Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics. Cancer Treat Rep 67:889-894
18. Bourgeois S, Gruol DJ, Newby RF, Rajah FM (1993) Expression of an mdr gene is associated with a new form of resistance to dexamethasone-induced apoptosis. Mol Endocrinol 7:840-851
19. Meijer OC, de Lange EC, Breimer DD, de Boer AG, Workel JO, de Kloet ER (1998) Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 139:1789-1793
20. Inoue Y, Iijima K, Nakamura H, Yoshikawa N (1999) Two-year cyclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 13:33-38
21. Farrell RJ, Kelleher D (2003) Glucocorticoid resistance in inflammatory bowel disease. J Endocrinol 178:339-346
22. Montano E, Schmitz M, Blaser K, Simon HU (1996) P-glycoprotein expression in circulating blood leukocytes of patients with steroid-resistant asthma. J Investig Allergol Clin Immunol 6:14-21
23. Szefler SJ (1991) Glucocorticoid therapy for asthma: Clinical pharmacology. J Allergy Clin Immunol 88:147-165
24. Wasilewska A, Zoch-Zwierz W, Pietruczuk M (2006) Expression of P-glycoprotein in lymphocytes of children with nephrotic syndrome treated with glucocorticoids. Eur J Pediatr (in press)
25. Ruiz-Soto R, Richaud-Patin Y, Lopez-Karpovitch X, Llorente L (2003) Multidrug resistance-1 (MDR-1) in autoimmune disorders III: Increased P-glycoprotein activity in lymphocytes from immune thrombocytopenic purpura patients. Exp Hematol 31:483-487
26. Diaz-Borjon A, Richaud-Patin Y, Alvarado de la Barrera C, Jakez-Ocampo J, Ruiz-Arguelles A, Llorente L (2000) Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II: Increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control. Joint Bone Spine 67:40-48
27. Tsujimura S, Saito K, Nakayamada S, Nakano K, Tanaka Y (2005) Clinical relevance of the expression of P-glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus. Arthritis Rheum 52:1676-1683
28. Maillefert JF, Maynadie M, Tebib JG, Aho S, Walker P, Chatard C, Dulieu V, Bouvier M, Carli PM, Tavernier C (1996) Expression of the multidrug resistance glycoprotein 170 in the peripheral blood lymphocytes of rheumatoid arthritis patients. The percentage of lymphocytes expressing glycoprotein 170 is increased in patients treated with prednisolone. Br J Rheumatol 35:430-435